Walvax Biotechnology Co., Ltd. (300142.SZ)
CNY 10.47
(4.7%)
CNY 10.47
(4.7%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.58 Billion CNY | 1.7% |
| 2022 | 15.32 Billion CNY | 12.09% |
| 2021 | 13.67 Billion CNY | 41.87% |
| 2020 | 9.63 Billion CNY | 37.34% |
| 2019 | 7.01 Billion CNY | -3.03% |
| 2018 | 7.23 Billion CNY | 23.16% |
| 2017 | 5.87 Billion CNY | -7.08% |
| 2016 | 6.32 Billion CNY | 1.06% |
| 2015 | 6.25 Billion CNY | 4.86% |
| 2014 | 5.96 Billion CNY | -2.74% |
| 2013 | 6.13 Billion CNY | 37.88% |
| 2012 | 4.45 Billion CNY | 47.99% |
| 2011 | 3 Billion CNY | 0.69% |
| 2010 | 2.98 Billion CNY | 673.44% |
| 2009 | 386.12 Million CNY | 27.9% |
| 2008 | 301.89 Million CNY | 38.79% |
| 2007 | 217.51 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 15.08 Billion CNY | -1.95% |
| 2024 Q3 | 15 Billion CNY | -0.55% |
| 2024 Q1 | 15.38 Billion CNY | -1.3% |
| 2023 Q4 | 15.58 Billion CNY | -0.01% |
| 2023 Q1 | 15.43 Billion CNY | 0.7% |
| 2023 FY | 15.58 Billion CNY | 1.7% |
| 2023 Q2 | 15.65 Billion CNY | 1.4% |
| 2023 Q3 | 15.59 Billion CNY | -0.38% |
| 2022 FY | 15.32 Billion CNY | 12.09% |
| 2022 Q1 | 14 Billion CNY | 2.44% |
| 2022 Q2 | 14.97 Billion CNY | 6.93% |
| 2022 Q3 | 14.84 Billion CNY | -0.9% |
| 2022 Q4 | 15.32 Billion CNY | 3.26% |
| 2021 Q2 | 10.96 Billion CNY | 6.59% |
| 2021 FY | 13.67 Billion CNY | 41.87% |
| 2021 Q1 | 10.29 Billion CNY | 6.77% |
| 2021 Q4 | 13.67 Billion CNY | 9.42% |
| 2021 Q3 | 12.49 Billion CNY | 13.93% |
| 2020 FY | 9.63 Billion CNY | 37.34% |
| 2020 Q4 | 9.63 Billion CNY | 12.63% |
| 2020 Q3 | 8.55 Billion CNY | 18.93% |
| 2020 Q1 | 6.91 Billion CNY | -1.47% |
| 2020 Q2 | 7.19 Billion CNY | 4.07% |
| 2019 Q2 | 7.02 Billion CNY | 0.81% |
| 2019 Q1 | 6.96 Billion CNY | -3.73% |
| 2019 FY | 7.01 Billion CNY | -3.03% |
| 2019 Q3 | 7.05 Billion CNY | 0.51% |
| 2019 Q4 | 7.01 Billion CNY | -0.59% |
| 2018 Q4 | 7.23 Billion CNY | 4.31% |
| 2018 FY | 7.23 Billion CNY | 23.16% |
| 2018 Q3 | 6.93 Billion CNY | 14.46% |
| 2018 Q2 | 6.06 Billion CNY | 0.26% |
| 2018 Q1 | 6.04 Billion CNY | 2.89% |
| 2017 Q1 | 5.94 Billion CNY | -5.98% |
| 2017 FY | 5.87 Billion CNY | -7.08% |
| 2017 Q4 | 5.87 Billion CNY | 2.72% |
| 2017 Q3 | 5.72 Billion CNY | 0.47% |
| 2017 Q2 | 5.69 Billion CNY | -4.24% |
| 2016 Q2 | 6.86 Billion CNY | -1.32% |
| 2016 Q1 | 6.95 Billion CNY | 11.14% |
| 2016 FY | 6.32 Billion CNY | 1.06% |
| 2016 Q4 | 6.32 Billion CNY | -4.98% |
| 2016 Q3 | 6.65 Billion CNY | -3.02% |
| 2015 FY | 6.25 Billion CNY | 4.86% |
| 2015 Q3 | 6.63 Billion CNY | 4.99% |
| 2015 Q2 | 6.31 Billion CNY | 8.39% |
| 2015 Q4 | 6.25 Billion CNY | -5.62% |
| 2015 Q1 | 5.82 Billion CNY | -2.38% |
| 2014 Q1 | 6.48 Billion CNY | 5.75% |
| 2014 Q4 | 5.96 Billion CNY | -1.8% |
| 2014 FY | 5.96 Billion CNY | -2.74% |
| 2014 Q2 | 6.24 Billion CNY | -3.68% |
| 2014 Q3 | 6.07 Billion CNY | -2.77% |
| 2013 FY | 6.13 Billion CNY | 37.88% |
| 2013 Q4 | 6.13 Billion CNY | 7.36% |
| 2013 Q3 | 5.71 Billion CNY | 25.65% |
| 2013 Q2 | 4.54 Billion CNY | 2.05% |
| 2013 Q1 | 4.45 Billion CNY | 0.16% |
| 2012 Q3 | 3.45 Billion CNY | 13.42% |
| 2012 FY | 4.45 Billion CNY | 47.99% |
| 2012 Q4 | 4.45 Billion CNY | 28.69% |
| 2012 Q1 | 2.97 Billion CNY | -0.95% |
| 2012 Q2 | 3.04 Billion CNY | 2.36% |
| 2011 Q3 | 2.89 Billion CNY | 0.4% |
| 2011 Q2 | 2.88 Billion CNY | 2.69% |
| 2011 Q1 | 2.8 Billion CNY | -5.97% |
| 2011 Q4 | 3 Billion CNY | 3.86% |
| 2011 FY | 3 Billion CNY | 0.69% |
| 2010 Q2 | 619.14 Million CNY | 0.0% |
| 2010 Q4 | 2.98 Billion CNY | 340.21% |
| 2010 FY | 2.98 Billion CNY | 673.44% |
| 2010 Q3 | 678.4 Million CNY | 9.57% |
| 2009 FY | 386.12 Million CNY | 27.9% |
| 2008 FY | 301.89 Million CNY | 38.79% |
| 2007 FY | 217.51 Million CNY | 0.0% |